Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Doxorubicin and Docetaxel in Stage III Breast Cancer
NCT00005800Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Apr 1999
- Primary completion
- Jan 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, docetaxel in breast cancer, sponsored by Moffitt Cancer Center. Started Apr 1999; status: completed.
02
Drugs
doxorubicindocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00005800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005800.